BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld
BioWorld
July 10, 2006
View Archived Issues
Replidyne Lowers Shares, Price, Raises $45M In IPO
It's a familiar story these days: Companies file for initial public offerings with high hopes but usually settle for less. (BioWorld Today)
Read More
Locus Entering Development Agreement With Japan's Ono
Read More
Sonus Bolsters Paclitaxel Bid With Buy Of Phase III Results
Read More
Novozymes Getting Protein Production, More From Delta
Read More
Other News To Note
Read More